CD4 and systemic lupus erythematosus: Furthermore, the investigators found that the effects were reversed when inhibitors of either miR-21 or miR-148a were transfected into CD4+ T cells isolated from SLE patients, implying that hypomethylation in CD4+ T cells can potentially be alleviated by inhibiting these miRNAs [71].